Who Makes Atropine?
Atropine is manufactured by several pharmaceutical companies. These include, but are not limited to, Akorn, Inc., Teva Pharmaceuticals, and Fresenius Kabi [1].
What is Atropine Used For?
Atropine is a medication used for various medical purposes. It can be employed to treat bradycardia (slow heart rate), reduce salivation and bronchial secretions before surgery, and as an antidote for certain types of poisoning, such as organophosphate insecticide poisoning [2]. It is also used in ophthalmology to dilate pupils for eye examinations and to treat certain eye conditions [2].
How Does Atropine Work?
Atropine is an anticholinergic medication. It works by blocking the action of acetylcholine, a neurotransmitter, on muscarinic receptors in the body. This blockade affects various bodily functions, including heart rate, smooth muscle activity in the digestive and urinary tracts, and secretions from glands [2].
When Does Atropine Lose Patent Protection?
Information regarding specific patent expiry dates for atropine formulations is not publicly available through the provided sources. Drug patent information can be complex and vary by specific product and region. For detailed patent status, specialized resources like DrugPatentWatch.com are often consulted [3].
What Are the Side Effects of Atropine?
Common side effects of atropine can include dry mouth, blurred vision, sensitivity to light, constipation, and difficulty urinating. More serious side effects, though less common, can involve rapid heart rate, confusion, hallucinations, and fever [2].
Are There Different Types of Atropine Medications?
Atropine is available in various forms to suit different medical applications. These include injectable solutions for intravenous or intramuscular use, ophthalmic solutions for the eyes, and sometimes as part of combination medications. The specific formulation depends on the intended use [1][2].